WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentPreface
View the documentIntroduction
Open this folder and view contentsParasitic infections
Open this folder and view contentsInsect and arachnid bites and stings
Open this folder and view contentsSuperficial fungal infections
Open this folder and view contentsSubcutaneous fungal infections
Open this folder and view contentsBacterial infections
Open this folder and view contentsViral infections
Open this folder and view contentsEczematous diseases
Open this folder and view contentsScaling diseases
Open this folder and view contentsPapulosquamous diseases
View the documentCutaneous reactions to drugs
Open this folder and view contentsPigmentary disorders
Open this folder and view contentsPremalignant lesions and malignant tumours
Open this folder and view contentsPhotodermatoses
Open this folder and view contentsBullous dermatoses
View the documentAlopecia areata
View the documentUrticaria
Open this folder and view contentsConditions common in children
View the documentAcne vulgaris
View the documentPruritus
View the documentTropical ulcers
Open this folder and view contentsAntimicrobial drugs
Open this folder and view contentsAntifugal drugs
Close this folderAntiseptic agents
View the documentAluminium diacetate
View the documentPotassium permanganate
View the documentSilver nitrate
Open this folder and view contentsKeratoplastic and keratolytic agents
Open this folder and view contentsScabicides and pediculicides
Open this folder and view contentsAnti-inflammatory and antipruritic drugs1
Open this folder and view contentsAntiallergics and drugs used in anaphylaxis
Open this folder and view contentsUltraviolet radiation-blocking agents (sunscreens)
Open this folder and view contentsMiscellaneous drugs
Open this folder and view contentsAnnex
View the documentSelected WHO Publications of Related Interest
View the documentBack cover
 

Aluminium diacetate

Solution, 13% (for dilution)

General information

Aluminium diacetate solution is an astringent that is used as an antiseptic agent. It is poorly absorbed, even when applied to damaged skin.

Clinical information

Uses

An antiseptic agent used in wet dressings to assist healing of suppurating superficial wounds, tropical ulcers and lesions caused by pemphigus and impetigo.

Dosage and administration

All doses are suitable for adults and children.

Suppurating superficial wounds and tropical ulcers:

A 1:20 (0.65%) dilution of the stock solution is used in wet dressings. The dressings should be applied for 0.5-2.0 hours each day and changed every 5-15 minutes. For tropical ulcers, a 2- to 4-week course of treatment with procaine benzylpenicillin is also required (see Benzylpenicillins - Tropical Ulcers).

Pemphigus:

Compresses soaked in a 1:2.6 (5%) dilution of the stock solution are applied every 4 hours.

Impetigo:

Superficial crusts should be gently separated with a 1:20 (0.65%) dilution of the stock solution.

Precautions

Dressings should not be applied under plastic or rubber occlusion.

Adverse effects

No adverse effects have been reported.

Storage

Solutions should be stored in well-closed containers.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018